Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18133543 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL309361 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2597399 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339907 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339908 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339906 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL27968096 | 0.89 | CYP1A2 (0.51) | CYP1A2ALDH1A1TSHRPPARG | |
| SCHEMBL1716637 | 0.88 | CYP1A2 (0.50) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2597391 | 0.83 | CYP1A2 (0.66) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL31048000 | 0.83 | CYP1A2 (0.66) | CYP1A2ALDH1A1TSHRFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| EP-1769687-B1 | FRESH CHEESE PRODUCTS CONTAINING BIOGENERATED FLAVOR COMPONENTS AND METHODS FOR PRODUCING | KRAFT FOODS GROUP BRANDS LLC (US) | 2015-10-07 | — | — | EP | claimed |
| US-7674489-B2 | Fresh cheese products containing biogenerated flavor components and methods for producing | KRAFT FOODS GLOBAL BRANDS LLC (US) | 2010-03-09 | — | — | US | claimed |
| US-20090169652-A1 | Personal Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-07-02 | — | — | US | claimed |
| US-20070077332-A1 | Fresh cheese products containing biogenerated flavor components and methods for producing | KRAFT FOODS HOLDINGS, INC. | 2007-04-05 | — | — | US | claimed |
| EP-1769687-A1 | Fresh cheese products containing biogenerated flavor components and methods for producing | Kraft Foods Holdings, Inc. (US) | 2007-04-04 | — | — | EP | claimed |
| US-5168054-A | From oxidized unsaturated fatty acids | PERNOD-RICARD (FR) | 1992-12-01 | — | — | US | claimed |
| US-12306078-B2 | Dynamic headspace vacuum transfer “in trap” extraction method and apparatus | CTC ANALYTICS AG (CH) | 2025-05-20 | — | — | US | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
| US-20210227863-A1 | HIGH INTENSITY SWEETENERS | SENOMYX, INC. | 2021-07-29 | — | — | US | disclosed |
| WO-2008003631-A1 | WASHING, CLEANING AND CARE PRODUCTS | HENKEL AG & CO. KGAA (DE) | 2008-01-10 | — | — | WO | disclosed |
| WO-2007090451-A1 | FLUID RESERVOIR | HENKEL AG & CO. KGAA (DE) | 2007-08-16 | — | — | WO | disclosed |
| US-20070077332-A1 | Fresh cheese products containing biogenerated flavor components and methods for producing | KRAFT FOODS HOLDINGS, INC. | 2007-04-05 | — | — | US | disclosed |
| EP-1769687-A1 | Fresh cheese products containing biogenerated flavor components and methods for producing | Kraft Foods Holdings, Inc. (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-0578388-B1 | Fermentation process for preparing 10-hydroxy-C18-carboxylic acid and gamma-dodecalactone derivatives | INT FLAVORS & FRAGRANCES INC (US) | 1998-11-04 | — | — | EP | disclosed |
| EP-0578388-A2 | Fermentation process for preparing 10-hydroxy-C18-carboxylic acid and gamma-dodecalactone derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1994-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | CYP1A2 4564/4885ALDH1A1 978/4885TSHR 3246/4885 |
| US-20090169652-A1 | Personal Care Compositions | CUTA, C5, F7 | CYP1A2 2799/4885ALDH1A1 3550/4885TSHR 4683/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | CYP1A2 4564/4885ALDH1A1 978/4885TSHR 3246/4885 |
| US-20210227863-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | CYP1A2 4564/4885ALDH1A1 978/4885TSHR 3246/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | CYP1A2 4564/4885ALDH1A1 978/4885TSHR 3246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.